Presently we are in a phase IIb / III study with L
Post# of 148173
(Total Views: 363)
Posted On: 04/16/2020 11:22:56 AM
Presently we are in a phase IIb / III study with Leronlimab. Assuming we meet endpoints, can the FDA THEN ask we complete a phase III trial since the previous trial was a IIb / III? A separate phase III trial seems the next step or do we move right to an approval ask?
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼